Global Drug Delivery Technology Market Size study, by Route of Administration (Oral, Parenteral, Intramuscular, Intravenous, Intra-arterial, Subcutaneous, Transdermal, Inhalation, Nasal) and End User (Hospitals, Clinics, Diagnostic Centres, Home Care, Oth

Global Drug Delivery Technology Market Size study, by Route of Administration (Oral, Parenteral, Intramuscular, Intravenous, Intra-arterial, Subcutaneous, Transdermal, Inhalation, Nasal) and End User (Hospitals, Clinics, Diagnostic Centres, Home Care, Others) and Regional Forecasts 2022-2032

The Global Drug Delivery Technology Market is valued approximately at USD 43.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2024-2032. Drug delivery systems represent a sophisticated method for administering therapeutic substances to achieve optimal therapeutic effects in humans and animals. These systems ensure the controlled release of active ingredients at the target site, enhancing efficacy and safety. The escalating demand for efficient delivery mechanisms for novel biopharmaceuticals is a significant driving force behind the market's expansion.

The surge in the incidence of chronic diseases, including cardiovascular diseases, diabetes, and cancer, coupled with rapid technological advancements and innovations, propels market growth. Additionally, the increasing focus on paediatric and geriatric patients, lifestyle changes due to urbanization, and the rising preference for minimally invasive surgeries further augment the demand for advanced drug delivery technologies. However, the market faces challenges such as side effects associated with drugs, patent expirations, and regulatory hurdles, which may impede growth. Despite these challenges, the market is poised for substantial growth, driven by rising investments in R&D and the growing biopharmaceutical market. The advantages of drug delivery technology, including enhanced efficacy, patient compliance, and targeted therapy, outweigh the disadvantages, positioning the market for continued expansion.

North America holds a prominent position in the global drug delivery technology market, accounting for a significant share due to heightened awareness of novel advancements and the presence of leading industry players. The United States and Canada dominate the regional market, contributing the majority of revenue. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing healthcare investments and the adoption of advanced medical technologies.

Major market players included in this report are:

Johnson and Johnson Pvt. Ltd

3M

Novartis AG

Pfizer Inc.

GlaxoSmithKline PLC

Merck & Co. Inc.

Antares Pharma

Generex Biotechnology

Sivida Corporation

Alkermes

The detailed segments and sub-segment of the market are explained below:

By Route of Administration:
• Oral Route
• Parenteral Route
• Subcutaneous Route
• Transdermal Route
• Inhalation Route
• Nasal Drug Delivery

By End User:
• Hospitals
• Clinics
• Diagnostic Centres
• Home Care Settings
• Others

By Region:
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.